Apyx Medical Corporation Forecast, price target & analysts
Apyx Medical Corporation Target price 2026 - Analyst rating & recommendation
Apyx Medical Corporation Classifications & Recommendation
Apyx Medical Corporation Price Target
| Target Price | $6.12 |
| Price | $2.96 |
| Potential |
106.76%
register free of charge
|
| Number of Estimates | 7 |
|
7 Analysts have issued a price target Apyx Medical Corporation 2027 .
The average Apyx Medical Corporation target price is $6.12.
This is
106.76%
register free of charge
$8.40
183.78%
register free of charge
$6.06
104.73%
register free of charge
|
|
| A rating was issued by 11 analysts: 10 Analysts recommend Apyx Medical Corporation to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Apyx Medical Corporation stock has an average upside potential 2027 of
106.76%
register free of charge
|
Sales and Margin forecast 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Revenue Million $ | 52.84 | 60.64 |
| 9.85% | 14.75% | |
| EBITDA Margin | -10.96% | -6.21% |
| 71.12% | 43.33% | |
| Net Margin | -21.21% | -19.56% |
| 56.50% | 7.80% |
7 Analysts have issued a sales forecast Apyx Medical Corporation 2026 . The average Apyx Medical Corporation sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Apyx Medical Corporation EBITDA forecast 2026. The average Apyx Medical Corporation EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Apyx Medical Corporation Analysts have issued a net profit forecast 2026. The average Apyx Medical Corporation net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030
| Dec '25 |
2026 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.27 | -0.28 |
| 59.09% | 3.70% | |
| P/E | negative | |
| EV/Sales | 2.18 |
7 Analysts have issued a Apyx Medical Corporation forecast for earnings per share. The average Apyx Medical Corporation EPS is
This results in the following potential growth metrics and future valuations:
Apyx Medical Corporation...
Current Apyx Medical Corporation Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HC Wainwright & Co. |
Locked
➜
Locked
|
Locked | Jul 13 2026 |
| BTIG |
Locked
➜
Locked
|
Locked | Mar 11 2026 |
| Craig-Hallum |
Locked
➜
Locked
|
Locked | Mar 11 2026 |
| Roth Capital |
Locked
➜
Locked
|
Locked | Dec 16 2025 |
| Citizens |
Locked
➜
Locked
|
Locked | Nov 12 2025 |
| BTIG |
Locked
➜
Locked
|
Locked | Oct 17 2024 |
| JMP Securities |
Locked
➜
Locked
|
Locked | Sep 16 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HC Wainwright & Co.:
Locked
➜
Locked
|
Jul 13 2026 |
|
Locked
BTIG:
Locked
➜
Locked
|
Mar 11 2026 |
|
Locked
Craig-Hallum:
Locked
➜
Locked
|
Mar 11 2026 |
|
Locked
Roth Capital:
Locked
➜
Locked
|
Dec 16 2025 |
|
Locked
Citizens:
Locked
➜
Locked
|
Nov 12 2025 |
|
Locked
BTIG:
Locked
➜
Locked
|
Oct 17 2024 |
|
Locked
JMP Securities:
Locked
➜
Locked
|
Sep 16 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
